大家在查： seaweeds equivocate 水害 enterclose 米夏尔 REN21 马里诺尼分厘卡 evade attack 克雷格•

gemcitabine

网络吉西他滨；健择；健泽

gemcitabine

网络释义

gemcitabine

吉西他滨

吉西他滨（Gemcitabine）725 mg/m2，静滴，7天后重复治疗，治疗3周，休息1周。长春瑞滨（Vinorelbine，Navelbine）30 m…

健择

新药健择（gemcitabine）、泰素（paclitaxel）、泰素帝（docetaxel）或诺维本（navalbine）等与顺铂或卡铂联合具有较好的 …

健泽

仅有5%的患者可接受手术切除；健泽（Gemcitabine）虽然是2006年后应用于临床并被认为是唯一有效的化疗药，但其临床反 …

吉西他宾

吉西他宾（Gemcitabine）单药（Gemcitabine 1000mg/m2 iv gtt，D1，D8，D15，Q4W）应用于晚期胰腺癌患者能够取得近期 …

化疗药物健泽

　尔后接受单一化疗药物健泽(gemcitabine)治疗数次, 追踪胸部X光片显示左侧肋膜积水增加, 於是在97年8月底使用健保给付之标 …

去氧胞苷

紫杉醇类（taxanes）、双氟去氧胞苷（gemcitabine）和喜树碱类（camptothecin）在临床前药理试验和ⅱ、ⅲ临床试验中已证 …

吉西他滨碱

武汉威顺达科技发展有限公司产品目录，中... ... Fenitrothion 杀螟硫磷 Gemcitabine 吉西他滨碱 Gentamycin sulfate 硫酸庆大 …

例句：

A recent phase III trial of the combination of gemcitabine with erlotinib was associated with a significant prolongation of survival .

一项最新的 III 期试验显示吉西他滨联合厄罗替尼布可以显著延长生存期。

Gemcitabine induced apoptosis and necrosis of purified MDSC in vitro in a time dependent manner.

体外吉西他滨时间依赖性诱导 MDSC 凋亡与坏死；

Gemcitabine is generally accepted as the standard chemotherapeutic agent for advanced pancreatic cancer .

以吉西他滨为基础的化疗是胰腺癌的主要治疗方法。

Many pancreatic tumor cells are resistant to gemcitabine , which makes the disease very difficult to treat , explained Govindarajan.

很多胰腺肿瘤细胞对吉西他滨耐药，导致这种疾病现在很难得到有效治疗。

Erlotinib is also being evaluated in combination with capecitabine in patients who failed first-line therapy with gemcitabine .

厄罗替尼布联合卡培他滨同样用于一线药物吉西他滨治疗失败的患者。

Results In primary breast cancer , the antitumor effect of taxane is better than anthracycline and gemcitabine (P 0 . 01 ).

对复发性乳腺癌患者，吉西他滨的疗效则明显优于蒽环类和紫杉类药物（P0 。01 ）。

Eligible patients were randomized to either treatment with gemcitabine alone (204 participants) or in combination with cisplatin (206 ).

这些满足适应症的患者被随机分至单用吉西他滨组（204 例）和顺铂 -吉西他滨联用组（206 例）。

After treatment with gemcitabine and CD40 antibody , the tumors shrank in 30% of the animals.

采用吉西他滨和 CD40 抗体治疗后，30%的小鼠肿瘤瘤体缩小。

The total yield of gemcitabine was 15 . 8%.

结果：合成了盐酸吉西他滨，总收率 15 .

The HR was 0 . 81 (p=0. 028), indicating a 19% reduction in the risk of death in patients treated with Tarceva plus gemcitabine.

危害比（HR ）为 0.81 （p=0.028 ），表示接受特罗凯联合吉西他滨治疗的患者的死亡危险降低了 19%。

Trials on gemcitabine plus cisplatin semimonthly therapy versus that of triweekly therapy in advanced non-small-cell lung cancer

吉西他滨联合顺铂双周方案与三周方案治疗晚期非小细胞肺癌的对比研究

Pharmacokinetics study of gemcitabine and its metabolite in Chinese patients with malignant tumor

静脉注射后吉西他滨及其代谢产物在人体内的药动学研究

Gemcitabine composed mainly of antineoplastic used for metastatic carcinoma of lung in 4 cases

吉西他滨为主治疗肺转移癌 4 例报告

Domestic or imported gemcitabine used in combination with cisplatin in the treatment of advanced non- small- cell lung cancer

国产与进口吉西他滨联合顺铂治疗非小细胞肺癌疗效与毒副作用观察

热词推荐

大家在看

man , . you 's " after ? : - Facebook what Yeah then your japan 4th as of own